These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11589514)

  • 21. Structural determinants critical for localization and signaling within the seventh transmembrane domain of the type 1 corticotropin releasing hormone receptor: lessons from the receptor variant R1d.
    Markovic D; Lehnert H; Levine MA; Grammatopoulos DK
    Mol Endocrinol; 2008 Nov; 22(11):2505-19. PubMed ID: 18772229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization and genetic analysis of functional corticotropin-releasing hormone receptors in primary cerebellar cultures.
    Barthel F; Loeffler JP
    J Neurochem; 1993 Feb; 60(2):696-703. PubMed ID: 8380441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential responses of corticotropin-releasing hormone receptor type 1 variants to protein kinase C phosphorylation.
    Markovic D; Papadopoulou N; Teli T; Randeva H; Levine MA; Hillhouse EW; Grammatopoulos DK
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1032-42. PubMed ID: 16956982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of corticotrophin releasing hormone (CRH) on cell viability and differentiation in the human BeWo choriocarcinoma cell line: a potential syncytialisation inducer distinct from cyclic adenosine monophosphate (cAMP).
    Chen Y; Allars M; Pan X; Maiti K; Angeli G; Smith R; Nicholson RC
    Reprod Biol Endocrinol; 2013 Apr; 11():30. PubMed ID: 23587111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRH-stimulation of cyclic adenosine 5'-monophosphate pathway is partially inhibited by the coexpression of CRH-R1 and CRH-R2alpha.
    Maya-Núñez G; Castro-Fernández C; Méndez JP
    Endocrine; 2005 Jun; 27(1):67-73. PubMed ID: 16077174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq-proteins.
    Grammatopoulos DK; Randeva HS; Levine MA; Katsanou ES; Hillhouse EW
    Mol Endocrinol; 2000 Dec; 14(12):2076-91. PubMed ID: 11117536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of corticotropin-releasing hormone and its R1 receptor in human endometrial stromal cells.
    Di Blasio AM; Pecori Giraldi F; Viganò P; Petraglia F; Vignali M; Cavagnini F
    J Clin Endocrinol Metab; 1997 May; 82(5):1594-7. PubMed ID: 9141555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor.
    Cao J; Papadopoulou N; Kempuraj D; Boucher WS; Sugimoto K; Cetrulo CL; Theoharides TC
    J Immunol; 2005 Jun; 174(12):7665-75. PubMed ID: 15944267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of corticotropin-releasing hormone type 1 receptor in paraventricular nucleus after acute stress.
    Imaki T; Katsumata H; Miyata M; Naruse M; Imaki J; Minami S
    Neuroendocrinology; 2001 May; 73(5):293-301. PubMed ID: 11399902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of corticotropin-releasing hormone (CRH) on endothelin-1 and NO release, mediated by CRH receptor subtype R2: a potential link between stress and endothelial dysfunction?
    Wilbert-Lampen U; Trapp A; Modrzik M; Fiedler B; Straube F; Plasse A
    J Psychosom Res; 2006 Oct; 61(4):453-60. PubMed ID: 17011352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticotropin-releasing hormone receptor expression and functional signaling in murine gonadotrope-like cells.
    Seasholtz AF; Ohman M; Wardani A; Thompson RC
    J Endocrinol; 2009 Feb; 200(2):223-32. PubMed ID: 19008330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRH inhibits cell growth of human endometrial adenocarcinoma cells via CRH-receptor 1-mediated activation of cAMP-PKA pathway.
    Graziani G; Tentori L; Portarena I; Barbarino M; Tringali G; Pozzoli G; Navarra P
    Endocrinology; 2002 Mar; 143(3):807-13. PubMed ID: 11861501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Action of corticotropin-releasing hormone on its own receptor type-1 in human placenta].
    Wang XD; Yu HY; He MM; Liu SY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):101-4. PubMed ID: 17294739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein kinase A-induced negative regulation of the corticotropin-releasing hormone R1alpha receptor-extracellularly regulated kinase signal transduction pathway: the critical role of Ser301 for signaling switch and selectivity.
    Papadopoulou N; Chen J; Randeva HS; Levine MA; Hillhouse EW; Grammatopoulos DK
    Mol Endocrinol; 2004 Mar; 18(3):624-39. PubMed ID: 14657255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes.
    Grammatopoulos DK; Dai Y; Randeva HS; Levine MA; Karteris E; Easton AJ; Hillhouse EW
    Mol Endocrinol; 1999 Dec; 13(12):2189-202. PubMed ID: 10598591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of a cutaneous corticotropin-releasing hormone system.
    Slominski A; Pisarchik A; Tobin DJ; Mazurkiewicz JE; Wortsman J
    Endocrinology; 2004 Feb; 145(2):941-50. PubMed ID: 14605004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Divergent effects of corticotropin releasing hormone on endothelial cell nitric oxide synthase are associated with different expression of CRH type 1 and 2 receptors.
    Cantarella G; Lempereur L; Lombardo G; Chiarenza A; Pafumi C; Zappalà G; Bernardini R
    Br J Pharmacol; 2001 Oct; 134(4):837-44. PubMed ID: 11606324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of treadmill running on brain activation and the corticotropin-releasing hormone system.
    Timofeeva E; Huang Q; Richard D
    Neuroendocrinology; 2003 Jun; 77(6):388-405. PubMed ID: 12845225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of corticotropin releasing hormone receptors type I and type II mRNA in suicide victims and controls.
    Hiroi N; Wong ML; Licinio J; Park C; Young M; Gold PW; Chrousos GP; Bornstein SR
    Mol Psychiatry; 2001 Sep; 6(5):540-6. PubMed ID: 11526468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel expression of type 1 corticotropin-releasing hormone receptor in multiple endocrine cell types in the murine anterior pituitary.
    Westphal NJ; Evans RT; Seasholtz AF
    Endocrinology; 2009 Jan; 150(1):260-7. PubMed ID: 18787023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.